- NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan
- NanoVibronix Issues Letter to Stockholders
- NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield
- NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract Award
- NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield
More ▼
Key statistics
On Friday, Nanovibronix Inc (NAOV:NAQ) closed at 0.7991, 17.95% above the 52 week low of 0.6775 set on May 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.7897 |
---|---|
High | 0.8294 |
Low | 0.7379 |
Bid | 0.7003 |
Offer | 0.7991 |
Previous close | 0.796 |
Average volume | 19.72k |
---|---|
Shares outstanding | 2.78m |
Free float | 2.77m |
P/E (TTM) | -- |
Market cap | 2.31m USD |
EPS (TTM) | -1.72 USD |
Data delayed at least 15 minutes, as of Jun 07 2024 20:57 BST.
More ▼